GIONCO DAVID (Chief Accounting Officer) sold 5.9% of their position (14.02K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $155.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/15/2019ACC: 0001104659-19-015343
Officer· Chief Accounting Officer
Since Feb 2019
-14.02K
Net shares
Net seller
$155.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
14.02K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−13.49K
Price / share
$11.11
Trade value
$149.90K
% of position
5.6%
3/11/2019
238.96K→225.47K
Common Stock
Direct
Shares
−530.00
Price / share
$11.05
Trade value
$5.86K
% of position
0.2%
3/12/2019
225.47K→224.94K
Total
Net shares
−14.02K
Net value
-$155.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2019 | S · Sale | −13.49K | $11.11 | $149.90K | 5.6% | 238.96K | 225.47K |
| Common Stock Direct | 3/12/2019 | S · Sale | −530.00 | $11.05 | $5.86K | 0.2% | 225.47K | 224.94K |
| Total | −14.02K | -$155.75K | ||||||
Derivative Transactions0
No derivative transactions reported